Skip to content

Second COVID-19 boosters now available at Rite Aid

Rite Aid

PHILADELPHIA — Rite Aid will begin administering a second booster of the mRNA Pfizer and Moderna COVID-19 vaccines for eligible individuals, following approval by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), the company said Wednesday.

Individuals aged 50 and older and certain immunocompromised individuals aged 12 and older may receive a second booster at least four months after their first booster. Eligible adults who received a primary vaccine and booster dose of Johnson & Johnson’s Janssen COVID-19 vaccine at least four months ago may also receive a second booster dose using an mRNA vaccine.

“Vaccination is critical in the continued fight against COVID-19, and as a proud partner in the Federal Retail Pharmacy Program, Rite Aid is committed to doing our part to help keep our communities healthy,” said Karen Staniforth, chief pharmacy officer at Rite Aid. “To date, Rite Aid has administered over 15 million COVID-19 vaccinations and encourages anyone who hasn’t received their primary vaccination series to do so, and to get their booster shots when eligible.”

Eligible customers may walk in immediately or schedule an appointment at www.riteaid.com/pharmacy/scheduler. Flu and other vaccines are also available in-store and can be scheduled via the online scheduling tool. Customers may receive their second booster dose at Rite Aid regardless of where they received their primary series or first booster.

Latest

CRN welcomes new member companies

CRN welcomes new member companies

This latest cohort reflects growing investment in data-driven decision-making, regulatory intelligence, and next-generation product development across the nutrition and health space.

Wegmans releases 2025 Impact Report

Wegmans releases 2025 Impact Report

From supporting hometown initiatives and feeding local families to fostering an inclusive workplace and advancing zero waste efforts, Wegmans continued to make a difference in 2025